m+Medelevator.RU
← Поиск публикаций
Therapeutics and clinical risk management · 2017

Comparison of the efficacy and safety of retroperitoneal laparoscopic and open surgery for the correction of retrocaval ureter.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Mao Lijun, Xu Kai, Ding Meng, Pan Jun, Guo Zhicheng

Аннотация

OBJECTIVE: The aim of this study was to compare the clinical efficacy and safety of retroperitoneal laparoscopic and open surgery for the correction of retrocaval ureter.

PATIENTS AND METHODS: Clinical data of 14 patients with retrocaval ureter were analyzed retrospectively. Among them, nine were treated by open surgical therapy and five by retroperitoneal laparoscopic surgery. The ureter was transpositioned to a normal anatomic position followed by laparoscopic intracorporeal uretero and ureteric anastomosis.

RESULTS: Open surgery was successfully performed in nine cases. The mean surgery time was 95.6±22.0 min, and blood loss was 108.6±34.5 mL. The mean hospitalization time was 14.8±1.1 days, and the recovery time was 52.8±1.3 days. Retroperitoneal laparoscopic surgery was successfully performed in five cases without conversion to open surgery and without severe perioperative complications. The mean surgery time was 112.0±42.1 min, and blood loss was 45.3±15.1 mL. The mean hospitalization time was 7.3±1.9 days, and the recovery time was 23.6±2.4 days. Postoperative urine leakage occurred in one patient. No postoperative ureter stenosis occurred in patients who were treated by retroperitoneal laparoscopic surgery.

CONCLUSION: Retroperitoneal laparoscopic ureteroplasty in patients with retrocaval ureter is safe and effective with less trauma and faster recovery and could be used as first choice for the treatment of retrocaval ureter.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты